Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Kymriah for relapsed or refractory large B-cell lymphoma

May 2, 2018

Spark Therapeutics sells priority review voucher to Jazz Pharmaceuticals

May 2, 2018

AbbVie submits European MAA for risankizumab in moderate to severe plaque psoriasis

May 2, 2018

FDA grants QIDP and fast track designations to oral SCY-078 for vulvovaginal candidiasis

May 2, 2018

Symphogen initiates first-in-human study of Sym-022 in advanced solid tumors or lymphomas

May 2, 2018

MEN-1611 demonstrates promising in vivo activity in various cancer models

May 2, 2018

Shire offers overview of first quarter 2018

May 2, 2018

Kodiak Sciences describes KSI-301, an anti-VEGF therapy with extended half-life

May 2, 2018

MedImmune presents novel bivalent bispecific antibody MEDI-1109

May 2, 2018

Starpharma completes rolling NDA submission for VivaGel BV

May 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...